Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles Congreve

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
ACS Chemical Neuroscience|March 4, 2022
Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand ComplexesAndrew D Cansfield, Mark A Ator, Joydeep Banerjee, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2019
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug designAlistair O'Brien, Stephen P Andrews, Asma H Baig, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsYoung Shin Cho, Hayley Angove, Christopher Brain, et al.
Nature|November 28, 2024
Addendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Nature|May 8, 2024
Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
ACS Chemical Neuroscience|March 4, 2022
Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand ComplexesAndrew D Cansfield, Mark A Ator, Joydeep Banerjee, et al.
Bioorganic & Medicinal Chemistry Letters|August 27, 2019
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure- based drug designAlistair O'Brien, Stephen P Andrews, Asma H Baig, et al.
Journal of Medicinal Chemistry|July 29, 2010
Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug designAndrew J Woodhead, Hayley Angove, Maria G Carr, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsYoung Shin Cho, Hayley Angove, Christopher Brain, et al.
Nature|November 28, 2024
Addendum: Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Nature|May 8, 2024
Accurate structure prediction of biomolecular interactions with AlphaFold 3Josh Abramson, Jonas Adler, Jack Dunger, et al.
Pageof 6